sch 23982 has been researched along with bromocriptine in 2 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (bromocriptine) | Trials (bromocriptine) | Recent Studies (post-2010) (bromocriptine) |
---|---|---|---|---|---|
87 | 0 | 0 | 7,121 | 727 | 499 |
Protein | Taxonomy | sch 23982 (IC50) | bromocriptine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.532 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 2.4 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2.4996 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.015 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0016 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 2.281 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.035 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.52 | |
D | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0056 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.889 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.03 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.036 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.532 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0056 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0006 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0083 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.022 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM | 1 |
Denis, P; Elena, PP; Lapalus, P; Nordmann, JP; Saraux, H | 1 |
2 other study(ies) available for sch 23982 and bromocriptine
Article | Year |
---|---|
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured | 1990 |
Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aged; Aged, 80 and over; Autoradiography; Benzazepines; Bromocriptine; Domperidone; Dopamine Antagonists; Humans; Iodine Radioisotopes; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Retina; Sulpiride | 1990 |